InterHealth Nutraceuticals Opposes Recent Petition to FDA to Treat Weight Loss Claims as Disease Claims

Manufacturers and Industry Associations Object

BENICIA, Calif. – May 28, 2008 – GlaxoSmithKline (NYSE: GSK) filed a joint citizen’s petition on April 22, 2008, which asked the Food and Drug Administration (FDA) to treat weight loss claims for dietary supplements as disease claims. InterHealth Nutraceuticals, other highly reputable manufacturers, and leading industry associations oppose the petition. InterHealth believes that weight loss claims are legitimate and appropriate for dietary supplements when supported by well-designed, peer-reviewed studies that show products to be both safe and efficacious.

Super CitriMax®, InterHealth’s (–)hydroxycitric acid (HCA) ingredient, has been the subject of comprehensive research that spans more than three decades and provides solid evidence of both its efficacy and safety. More than 20 such papers have been published in peer-reviewed scientific journals. Studies include clinical research on weight loss, appetite control, calorie reduction and fat-burning effects. Super CitriMax® has gone through a rigorous process to be affirmed GRAS (Generally Regarded As Safe) by the Burdock Group, the nation’s leading toxicology specialists in evaluating the safety of food and beverage ingredients.

“InterHealth is working with its customers and industry organizations to defend the industry’s and consumers’ rights in this area,” said InterHealth CEO Paul Dijkstra.

About InterHealth Nutraceuticals, Inc.
InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. The company’s products include Super CitriMax®, ChromeMate®, Aller-7®, OptiBerry®, UC-II®, L-OptiZinc®, Protykin® and ZMA®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit the website at
# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.